Trials / Unknown
UnknownNCT04938375
Safety Profile of the Combination of Levosimendan and IV Beta Blocker in Cardiogenic Shock: a Retrospective Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety profile of the combination of Levosimendan and beta blocker in cardiogenic shock with arrythmia.
Conditions
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2021-06-30
- Completion
- 2021-07-30
- First posted
- 2021-06-24
- Last updated
- 2021-06-24
Source: ClinicalTrials.gov record NCT04938375. Inclusion in this directory is not an endorsement.